oxidopamine has been researched along with Allergic Encephalomyelitis in 8 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhowmick, S | 1 |
| Singh, A | 1 |
| Flavell, RA | 1 |
| Clark, RB | 1 |
| O'Rourke, J | 1 |
| Cone, RE | 1 |
| Grebe, KM | 1 |
| Fainstein, N | 1 |
| Einstein, O | 1 |
| Cohen, ME | 1 |
| Brill, L | 1 |
| Lavon, I | 1 |
| Ben-Hur, T | 1 |
| de Lago, E | 1 |
| Fernández-Ruiz, J | 1 |
| Ortega-Gutiérrez, S | 1 |
| Cabranes, A | 1 |
| Pryce, G | 1 |
| Baker, D | 1 |
| López-Rodríguez, M | 1 |
| Ramos, JA | 1 |
| Pál, E | 1 |
| Yamamura, T | 1 |
| Tabira, T | 1 |
| Konkol, RJ | 2 |
| Wesselmann, U | 1 |
| Karpus, WJ | 2 |
| Leo, GL | 1 |
| Killen, JA | 2 |
| Roerig, DL | 1 |
| Leonard, JP | 1 |
| MacKenzie, FJ | 1 |
| Patel, HA | 1 |
| Cuzner, ML | 1 |
8 other studies available for oxidopamine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism.
Topics: Animals; Antigen-Presenting Cells; Encephalomyelitis, Autoimmune, Experimental; Lymph Nodes; Mice; M | 2009 |
Editorial: regulation of the regulator: sympathetic nervous system control of regulatory T cells.
Topics: Animals; Antigen-Presenting Cells; Encephalomyelitis, Autoimmune, Experimental; Lymph Nodes; Mice; M | 2009 |
Time limited immunomodulatory functions of transplanted neural precursor cells.
Topics: Adrenergic Agents; Animals; Cell Proliferation; Corpus Striatum; Cytokines; Disease Models, Animal; | 2013 |
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Arachidonic Acids; Brain Chemistry; D | 2006 |
Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice.
Topics: Animals; Autonomic Nervous System; Cell Division; Down-Regulation; Encephalomyelitis, Autoimmune, Ex | 1999 |
Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine.
Topics: Animals; Body Weight; Brain; Catecholamines; Cerebral Ventricles; Cisterna Magna; Decerebrate State; | 1990 |
Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis.
Topics: Adrenal Glands; Adrenalectomy; Animals; Corticosterone; Encephalomyelitis, Autoimmune, Experimental; | 1991 |
Central catecholamine neurotoxin administration. 1. Immunological changes associated with the suppression of experimental autoimmune encephalomyelitis.
Topics: Animals; Catecholamines; Encephalomyelitis, Autoimmune, Experimental; Hydroxydopamines; Immunosuppre | 1988 |